Clinical data indicate that high levels of another lncRNA, namely Taurine Upregulated Gene 1 (TUG1), were also associated with recurrence of CRC in patients receiving 5FU-based chemotherapy (Wang et al. 2019a). This evidence concerns the gene TUG1 and colorectal carcinoma.